Spinocerebellar ataxias (SCAs) are a heterogeneous group of neurodegenerative disorders currently associated with 27 genes. The most frequent types are caused by expansions in coding CAG repeats. The frequency of SCA subtypes varies among populations. We examined the occurrence of rare SCAs, SCA8, SCA12, SCA17 and dentatorubro-pallidoluysian atrophy (DRPLA), in the Czech population from where the data were missing. We analyzed causal gene expansions in 515 familial and sporadic ataxic patients negatively tested for SCA1-3 and SCA6-7. Pathogenic SCA8 and SCA17 expansions were identified in eight and five patients, respectively. Tay-Sachs disease was later diagnosed in one patient with an SCA8 expansion and the diagnosis of multiple sclerosis (MS) was suspected in two other patients with SCA8 expansions. These findings are probably coincidental, although the participation of SCA8 expansions in the susceptibility to MS and disease progression cannot be fully excluded. None of the patients had pathogenic SCA12 or DRPLA expansions. However, three patients had intermediate SCA12 alleles out of the normal range with 36 and 43 CAGs. Amyotrophic lateral sclerosis (ALS) was probable in the patient with 43 CAGs. This coincidence is remarkable, especially in the context with the recently identified predisposing role of longer SCA2 alleles in ALS. Five families with SCA17 represent a significant portion of ataxic patients and this should be reflected in the diagnostics of SCAs in the Czech population. SCA8 expansions must be considered after careful clinical evaluation.

Department of Biology and Medical Genetics Charles University 2nd Faculty of Medicine and University Hospital Motol Prague Czech Republic

Zobrazit více v PubMed

J Neurol. 2002 Jul;249(7):923-9 PubMed

Nat Genet. 2000 Mar;24(3):214-5 PubMed

Am J Hum Genet. 2000 Mar;66(3):819-29 PubMed

Cerebellum. 2010 Jun;9(2):148-66 PubMed

Hum Mol Genet. 1999 Oct;8(11):2047-53 PubMed

J Neurol. 2004 Aug;251(8):1023-4 PubMed

Ann Hum Genet. 2005 Sep;69(Pt 5):528-34 PubMed

Nature. 2010 Aug 26;466(7310):1069-75 PubMed

Eur J Neurosci. 2002 Dec;16(11):2039-48 PubMed

Nat Genet. 1994 Jan;6(1):9-13 PubMed

Nat Genet. 1999 Apr;21(4):379-84 PubMed

Mov Disord. 2010 Jul 15;25(9):1269-73 PubMed

J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1396-9 PubMed

Mov Disord. 2011 May;26(6):1134-41 PubMed

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Jun;36(6):482-9 PubMed

Mov Disord. 2009 Aug 15;24(11):1636-40 PubMed

Ann Neurol. 2007 Jun;61(6):607-10 PubMed

Ann Neurol. 2001 Jan;49(1):117-21 PubMed

Neurology. 2003 Nov 25;61(10):1441-3 PubMed

Ann Neurol. 2001 Dec;50(6):796-800 PubMed

J Med Genet. 1996 Dec;33(12):1022-6 PubMed

Adv Neurol. 1993;61:1-14 PubMed

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2011 Apr;28(2):137-41 PubMed

Cerebellum. 2008;7(2):150-8 PubMed

Cerebellum. 2012 Dec;11(4):821-7 PubMed

Cerebellum. 2008;7(2):170-8 PubMed

J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):937-8 PubMed

Cerebellum. 2007;6(4):300-7 PubMed

Nat Genet. 1994 Jan;6(1):14-8 PubMed

Neurosci Lett. 2007 Dec 11;429(1):28-32 PubMed

J Biol Chem. 2003 Jul 4;278(27):24976-85 PubMed

Genomics. 1993 Jun;16(3):572-9 PubMed

J Appl Genet. 2004;45(1):101-5 PubMed

Biochemistry. 1991 Apr 16;30(15):3589-97 PubMed

Am J Hum Genet. 1998 Oct;63(4):1060-6 PubMed

J Clin Invest. 2010 Oct;120(10):3673-9 PubMed

Lancet Neurol. 2010 Sep;9(9):885-94 PubMed

Eur J Neurol. 2005 Nov;12(11):851-7 PubMed

Nat Genet. 1999 Dec;23(4):391-2 PubMed

Hum Genet. 2010 Aug;128(2):205-12 PubMed

J Biol Chem. 2008 Dec 26;283(52):36241-8 PubMed

Cerebellum. 2008;7(2):101-5 PubMed

Am J Hum Genet. 2004 Jul;75(1):3-16 PubMed